CTX131

WIPO WIPO 2022

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark CTX131 was filed as Word mark on 09/08/2022 at the World Intellectual Property Organization.

Trademark Details Last update: April 4, 2023

Trademark form Word mark
File reference 1688473
Countries Switzerland em United Kingdom
Base trademark US No. 97371566, April 20, 2022
Application date September 8, 2022
Expiration date September 8, 2032

Trademark owner

Baarerstrasse 14
6300 ZUG V8
CH

Trademark representatives

233 South Wacker Drive, 6300 Willis Tower US

goods and services

05 Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer
42 Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

Trademark history

Date Document number Area Entry
April 3, 2023 2023/14 Gaz GB Rejection
March 7, 2023 2023/10 Gaz EM Rejection
September 8, 2022 2022/39 Gaz US Registration

ID: 141688473